What did Barclays, Wolfe, and Exane do in the March 12, 2026 DG analyst rating update?

On March 12, 2026, Barclays reiterated **Overweight**, Wolfe Research reiterated **Outperform**, and Exane BNP Paribas reiterated **Neutral** on DG. All three firms praised Q4 results, but none issued a new price target.

How should investors interpret the DG analyst rating mix of Overweight, Outperform, and Neutral?

Two bullish stances and one neutral suggest cautious optimism. Investors should focus on execution, comps, and margin trends rather than headline rating shifts, since these were reiterations not upgrades or downgrades.

Did any firm issue a new DG price target in the March 12 notes?

No. The March 12 reports from Barclays, Wolfe, and Exane reiterated ratings and commentary without publishing new DG price targets. Investors should watch future updates for revised targets.

How does the Meyka grade relate to the DG analyst rating updates?

Meyka AI rates DG **B+**, reflecting benchmark and sector comparisons, growth metrics, and analyst consensus. The March 12 reiterations reinforce our view but do not change the grade alone. This is informational, not financial advice.

Analyst Ratings

Barclays Maintains Overweight on Dollar General (DG) March 12, 2026

ByHuzaifa Zahoor March 13, 2026March 13, 2026

Barclays maintained its Overweight rating on Dollar General Corporation (DG) on March 12, 2026, the lead call in a set of three reiterations that morning. The DG analyst rating action follows similar holds by Wolfe Research, which kept Outperform, and Exane BNP Paribas, which stayed at Neutral. All three firms cited a stronger Q4 and improved underlying trends. Investors should note these are reiterations, not new upgrades or downgrades, and the mixed stance leaves price discovery to upcoming quarters and execution on margin and traffic metrics.